|
BRCC3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.00750000000683E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.85850000003585E-07 |
| Normal-vs-Stage2 |
8.171400E-01 |
| Normal-vs-Stage3 |
9.295000E-01 |
| Normal-vs-Stage4 |
4.720300E-02 |
| Stage1-vs-Stage2 |
2.948800E-01 |
| Stage1-vs-Stage3 |
2.913900E-02 |
| Stage1-vs-Stage4 |
7.602600E-01 |
| Stage2-vs-Stage3 |
7.902200E-01 |
| Stage2-vs-Stage4 |
2.853200E-01 |
| Stage3-vs-Stage4 |
1.267190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.78760000000478E-05 |
| Normal-vs-AfricanAmerican |
8.754300E-02 |
| Normal-vs-Asian |
8.212800E-01 |
| Caucasian-vs-AfricanAmerican |
6.787000E-01 |
| Caucasian-vs-Asian |
5.310600E-01 |
| AfricanAmerican-vs-Asian |
7.655600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.17699999641263E-08 |
| Normal-vs-Female |
6.150800E-01 |
| Male-vs-Female |
2.353400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.960640E-03 |
| Normal-vs-Extreme_Weight |
7.04769997916799E-09 |
| Normal-vs-Obese |
4.811400E-01 |
| Normal-vs-Extreme_Obese |
3.126600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.017600E-01 |
| Normal_Weight-vs-Obese |
8.236000E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.377600E-01 |
| Extreme_Weight-vs-Obese |
5.303900E-03 |
| Extreme_Weight-vs-Extreme_Obese |
2.021000E-01 |
| Obese-vs-Extreme_Obese |
6.393800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.819400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.758600E-03 |
| Normal-vs-Age(61-80Yrs) |
8.29469999999999E-05 |
| Normal-vs-Age(81-100Yrs) |
1.022040E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.651200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.240790E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.323900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.783620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.115200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.077400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.78879999999104E-05 |
| Normal-VS-Type2 PRCC |
3.357900E-02 |
| Normal-VS-KIRP CIMP |
6.393200E-01 |
| Normal-VS-Unclassified PRCC |
6.203400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.373200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.089700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.935600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.109000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.250800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.151800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.444000E-03 |
| Normal-vs-N1 |
6.825400E-01 |
| Normal-vs-N2 |
2.26139999999209E-05 |
| N0-vs-N1 |
2.727900E-02 |
| N0-vs-N2 |
2.982400E-01 |
| N1-vs-N2 |
4.706000E-02 |
|
|
